Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant-Reference-Cited by-同舟云学术

Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant

Published:2011-03-01 Issue:5 Volume:203 Page:666-673
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Belshe Robert B.¹,Frey Sharon E.¹,Graham Irene¹,Mulligan Mark J.²,Edupuganti Srilatha²,Jackson Lisa A.³,Wald Anna⁴,Poland Gregory⁵,Jacobson Robert⁵,Keyserling Harry L.⁶,Spearman Paul⁶,Hill Heather⁷,Wolff Mark⁷,

Affiliation:

1. Division of Infectious Diseases and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri

2. Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia

3. Group Health Research Institute, Seattle, Washington

4. Department of Medicine, Epidemiology, and Laboratory Medicine, University of Washington, Seattle, Washington

5. Departments of Internal Medicine and Pediatric and Adolescent Medicine, Vaccine Research Group, Mayo Clinic, Rochester, Minnesota

6. Division of Pediatric Infectious Diseases, Department of Pediatrics, Emory University, Atlanta, Georgia

7. The EMMES Corporation, Rockville, Maryland

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/203/5/666/18064433/jiq093.pdf

Reference12 articles.

1. Avian influenza A (H5N1) in 10 patients in Vietnam;Tran;N Engl J Med,2004

2. Probable person-to-person transmission of avian influenza A (H5N1);Ungchusak;N Engl J Med,2005

3. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza;Nicholson;Lancet,2001

4. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans;Treanor;Vaccine,2001

5. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine;Treanor;N Engl J Med,2006

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avian Influenza Virus A(H5Nx) and Prepandemic Candidate Vaccines: State of the Art;International Journal of Molecular Sciences;2024-08-05

2. A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults;Clinical Infectious Diseases;2024-03-27

3. Non-clinical evaluation of local and systemic immunity induced by different vaccination strategies of the candidate tuberculosis vaccine M72/AS01;Tuberculosis;2023-12

4. Hemagglutinin expressed by yeast reshapes immune microenvironment and gut microbiota to trigger diverse anti-infection response in infected birds;Frontiers in Immunology;2023-04-18

5. AddaVax-Adjuvanted H5N8 Inactivated Vaccine Induces Robust Humoral Immune Response against Different Clades of H5 Viruses;Vaccines;2022-10-09